Vaishali Pharma Limited (VAISHALI) — Cash Flow-to-Debt Ratio
Vaishali Pharma Limited (VAISHALI) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of Rs20.46 Million could theoretically repay 0% of its total liabilities (Rs545.40 Million) in one year. See VAISHALI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vaishali Pharma Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Vaishali Pharma Limited across 13 annual periods. Also explore net asset momentum of Vaishali Pharma Limited to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Vaishali Pharma Limited (2013–2025)
Year-by-year debt coverage analysis for Vaishali Pharma Limited. For market capitalisation and broader financial context, see how much is Vaishali Pharma Limited worth.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.40x | Rs-180.38 Million | Rs449.29 Million | ▼ -1947.2% |
| 2024 | 0.02x | Rs8.07 Million | Rs371.16 Million | ▼ -22.7% |
| 2023 | 0.03x | Rs10.80 Million | Rs383.76 Million | ▲ +17.9% |
| 2022 | 0.02x | Rs13.19 Million | Rs552.70 Million | ▼ -24.4% |
| 2021 | 0.03x | Rs20.11 Million | Rs637.05 Million | ▼ -56.0% |
| 2020 | 0.07x | Rs32.19 Million | Rs448.23 Million | ▲ +19.4% |
| 2019 | 0.06x | Rs28.48 Million | Rs473.52 Million | ▲ +127.8% |
| 2018 | -0.22x | Rs-94.60 Million | Rs437.22 Million | ▼ -1135.9% |
| 2017 | 0.02x | Rs8.52 Million | Rs407.80 Million | ▼ -78.8% |
| 2016 | 0.10x | Rs45.88 Million | Rs465.19 Million | ▲ +213.0% |
| 2015 | -0.09x | Rs-37.16 Million | Rs425.60 Million | ▲ +37.5% |
| 2014 | -0.14x | Rs-70.40 Million | Rs503.56 Million | ▼ -268.7% |
| 2013 | 0.08x | Rs37.97 Million | Rs458.09 Million | — |